Listed life sciences firm forms new 100% owned subsidiary
Life sciences business OptiBiotix Health has announced the formation of a 100% owned subsidiary, ProBiotix Health Limited, and the appointment of Adam Reynolds as Non-Executive Chairman to ProBiotix's Board.
The York-based firm develops compounds to tackle obesity, high cholesterol and skin care.
In July 2016, OptiBiotix announced a strategy to develop its technology platforms into separate divisions; each containing its own technology platform, intellectual property portfolio and partner agreements.
These divisions could bec... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
